Article Details

Seneca Biopharma's Merger Partner Leading BioSciences' Lead Asset Shows Efficacy In Lower ...

Retrieved on: 2021-04-20 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

Seneca Biopharma's Merger Partner Leading BioSciences' Lead Asset Shows Efficacy In Lower .... View article details on hiswai:

Excerpt

... agreement for a reverse merger with Seneca Biopharma Inc (NASDAQ: SNCA) has announced data from an open-label gastrointestinal (GI) surgery ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up